Advertisement

Analysis of fresh frozen plasma utilization indications in children: An audit of a tertiary care hospital in Turkey

      Abstract

      Background

      Although indications of fresh frozen plasma (FFP) usage are limited to certain circumstances in children, there is an increasing trend towards inappropriate usage are reported in clinical practice. The aim of this study was to evaluate the appropriateness of pediatric FFP utilization in our tertiary care hospital.

      Methods

      This prospective observational study was conducted at a tertiary care academic pediatric hospital. All FFP orders were evaluated for appropriateness over a 4-monts period by 2 hematologists. Data collected include demographic information, diagnosis, FFP transfusion indication, pre-transfusion coagulation tests, surgical procedure or bleeding status, and transfusion reactions.

      Results

      Three hundred twenty-four patients (57 % males, 43 % females) were transfused in 987 episodes. The mean age of the patients was 5.4±5.7 years. The majority of the patients (33 %) were under 1 y of age and the products were primarily utilized by pediatric and cardiovascular intensive care units. Pre-transfusion coagulation testing was only available in 674 (68 %) of the transfusion episodes. The rate of appropriate FFP transfusion episodes was 59 % (587/987). Inappropriate usage was mostly related to sepsis and minor coagulation abnormalities without bleeding. The higher rates of inappropriate transfusion orders were observed in pediatric and neonatal intensive care units, and hematology/oncology departments.

      Conclusions

      Inappropriate use of FFP in children remains a significant challenge. The regular audit and sustainable education programs targeting the efficient use of FFP for health professionals at the national level can improve transfusion practices.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Duguid J.
        • O’Shaughnessy D.F.
        • Atterbury C.
        • Maggs P.B.
        • Murphy M.
        • Thomas D.
        • et al.
        Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.
        Br J Haematol. 2004; 126: 11-28
      1. Ipa U. Türkiye’de Kan Tedarik Sisteminin Güçlendirilmesi Teknik Destek Projesi T.C. Sağlık Bakanlığı - E-Kütüphane Sistemi. 2020; Available from: https://sbu.saglik.gov.tr/Ekutuphane/Yayin/523.

        • Stainsby D.
        • Jones H.
        • Asher D.
        • Atterbury C.
        • Boncinelli A.
        • Brant L.
        • et al.
        Serious hazards of transfusion: a decade of hemovigilance in the UK.
        Transfus Med Rev. 2006; 20: 273-282
      2. Bahadur S., Sethi N., Pahuja S.. Audit of Pediatric Transfusion Practices in a Tertiary Care Hospital. 2014;

        • Tinmouth A.
        • Thompson T.
        • Arnold D.M.
        • Callum J.L.
        • Gagliardi K.
        Reveals a high rate of inappropriate transfusions. 2013; 53: 2222-2229
        • Mirzamani N.
        • Molana A.
        • Poorani E.
        Transfusion and apheresis science evaluation of appropriate usage of fresh frozen plasma: results of a regional audit in Iran.
        Transfus Apher Sci. 2009; 40: 109-113https://doi.org/10.1016/j.transci.2009.01.018
        • Lieberman L.
        • Pendergrast J.
        • Lin Y.
        • Lau W.
        • Cserti-gazdewich C.
        • Callum J.
        Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: an audit of transfusion appropriateness in Utilization Education and Safety in transfusion.
        Res Collab. 2017; 1: 1-8
        • Emektar E.
        • Dagar S.
        • Corbacioglu S.K.
        • Uzunosmanoglu H.
        • Oncul M.V.
        • Cevik Y.
        The evaluation of the audit of Fresh-Frozen Plasma (FFP) usage in emergency department. Turkish.
        J Emerg Med. 2016; 16: 137-140https://doi.org/10.1016/j.tjem.2016.08.002
        • Altuntas N.
        • Yenicesu I.
        • Beken S.
        • Kulali F.
        • Burcu Belen F.
        • Hirfanoglu I.M.
        • et al.
        Clinical use of fresh-frozen plasma in neonatal intensive care unit.
        Transfus Apher Sci. 2012; 47: 91-94
        • Dellinger R.P.
        • Carlet J.M.
        • Masur H.
        • Gerlach H.
        • Calandra T.
        • Cohen J.
        • et al.
        Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.
        Crit Care Med. 2004; 32: 858-873
        • Deloughery T.G.
        • Liebler J.M.
        • Simonds V.
        • Goodnight S.H.
        Invasive line placement in critically ill patients: do hemostatic defects matter?.
        Transfusion. 1996; 36: 827-831
        • Fisher N.C.
        • Mutimer D.J.
        Central venous cannulation in patients with liver disease and coagulopathy - a prospective audit.
        Intensive Care Med. 1999; 25: 481-485
        • Chee Y.L.
        • Crawford J.C.
        • Watson H.G.
        • Greaves M.
        Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures: British Committee for Standards in Haematology.
        Br J Haematol. 2008; 140 (Mar): 496-504
        • Abdel-Wahab O.I.
        • Healy B.
        • Dzik W.H.
        Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.
        Transfusion. 2006; 46: 1279-1285
        • Wikkelsø A.
        • Wetterslev J.
        • Møller A.M.A.A.
        Thromboelastography (T.E.G.) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding (review).
        Cochrane Database Sys Rev. 2016; 22: CD007871
        • Karam O.
        • Demaret P.
        • Shefler A.
        • Leteurtre S.
        • Spinella P.C.
        • Stanworth S.J.
        • et al.
        Indications and effects of plasma transfusions in critically ill children.
        Am J Respir Crit Care Med. 2015; 191: 1395-1402
        • TAYFUN KÜPESİZ F.
        • ANDIC N.
        • SEZGİN EVİM M.
        • EKER İ.
        • AYDİN F.
        • TÜYSÜZ G.
        • et al.
        Evaluation of the achievement of hematologists to transfusion medicine education with self-assessment questionnaire in Turkey.
        Tıp Eğitimi Dünyası. 2020; 23: 128-143